NCT04010045View on ClinicalTrials.gov

REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study

TerminatedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

October 15, 2020

Study Completion Date

October 15, 2020

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Endovascular Treatment of PAD

PAD endovascular treatment using the DABRA Laser System + other FDA cleared/ approved devices for the treatment of PAD.

Trial Locations (1)

73116

NAADI Healthcare, Oklahoma City

Sponsors

Lead Sponsor

Ra Medical Systems
All Listed Sponsors
lead

Ra Medical Systems

INDUSTRY